The F238L Point Mutation in the Cannabinoid Type 1 Receptor Enhances Basal Endocytosis via Lipid Rafts

• Melanie Wickert,
• Keri L. Hildick,
• Gemma L. Baillie,
• Ruth Jelinek,
• Alejandro Aparisi Rey,
• Krisztina Monory,
• Miriam Schneider,
• Miriam Schneider,
• Ruth A. Ross,
• Jeremy M. Henley,
• Beat Lutz,
• Beat Lutz

Affiliations

Melanie Wickert

Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Keri L. Hildick

School of Biochemistry, University of Bristol, Bristol, United Kingdom

Gemma L. Baillie

Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Ruth Jelinek

Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Alejandro Aparisi Rey

Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Krisztina Monory

Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Miriam Schneider

Institute of Psychopharmacology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

Miriam Schneider

Department of Psychology, University of Heidelberg, Heidelberg, Germany

Ruth A. Ross

Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Jeremy M. Henley

School of Biochemistry, University of Bristol, Bristol, United Kingdom

Beat Lutz

Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Beat Lutz

German Resilience Center (DRZ), University Medical Center of the Johannes Gutenberg University, Mainz, Germany